Racura Oncology Ltd (ASX:RAC) Directors Insider Transactions
The Directors and Chief Executives of Racura Oncology Ltd (ASX:RAC) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Racura Oncology Ltd's shares in the stock market. Below table shows the list of insider transactions as reported by Racura Oncology Ltd to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Racura Oncology Ltd Directors/Insider Transactions Activity
List of Insider trades activity from Racura Oncology Ltd (RAC).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 19 Feb 2026 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 100,000 | 88,220 | Other at price 0.88 per share. |
| 13 Feb 2026 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 14,000 | 78,082 | Sale at price 5.58 per share. |
| 11 Feb 2026 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 62,631 | 78,664 | Purchase at price 1.26 per share. |
| 22 Jan 2026 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 400,000 | - | - |
| 18 Dec 2025 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 312,218 | - | - |
| 26 Nov 2025 | Smith (Peter) | Executive Chairman | 9,433 | 16,304 | Purchase at price 1.73 per share. |
| 26 Nov 2025 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 22,000 | 38,271 | Purchase at price 1.74 per share. |
| 25 Nov 2025 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 470,545 | - | - |
| 01 Sep 2024 | Lynch (Phillip) | Retired | 450,606 | - | - |
| 01 Sep 2024 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 0 | - | - |
| 16 Aug 2024 | Tillett (Daniel Ph.D.) | Chief Executive Officer | 945,320 | - | - |
| 30 May 2024 | Harney (Mary Cecilia) | Non Executive Chairman | 1,170 | 581 | Exercise at price 0.50 per share. |
| 23 May 2024 | Lynch (Phillip) | Managing Director | 21,457 | 10,629 | Exercise at price 0.50 per share. |